Genscript Biotech sees highest filings and grants during August in Q3 2023

Genscript Biotech has been focused on protecting inventions in United States(US) with 9 publications in Q3 2023

The United States(US) Patent Office dominates the patent filings and grants with nearly 26% filings and 60% grants. The United States(US), China(CN), World Intellectual Property Organization(WIPO), and South Korea(KR) patent Office are among the top ten patent offices where Genscript Biotech is filings its patents. Among the top granted patent authorities, Genscript Biotech has 60% of its grants in United States(US), 20% in European Patent Office(EPO), and 0% in China(CN).

Johnson & Johnson could be the strongest competitor for Genscript Biotech

Johnson & Johnson and Pfizer secured the top positions according to recent patent publication data.

Patents related to rare diseases and cell & gene therapy lead Genscript Biotech’s portfolio

Genscript Biotech has the highest number of patents in rare diseases followed by, cell & gene therapy and immuno-oncology. For rare diseases, nearly 47% of patents were filed and 0% of patents were granted in Q3 2023.

Cell therapy related patents lead Genscript Biotech portfolio followed by advanced malignancy, and multiple myeloma (kahler disease)

Genscript Biotech has highest number of patents in cell therapy followed by advanced malignancy, multiple myeloma (kahler disease), non-hodgkin lymphoma and acute lymphocytic leukemia (all, acute lymphoblastic leukemia). For cell therapy, nearly 5% of patents were filed and 0% of patents were granted in Q3 2023.

For comprehensive analysis of Genscript Biotech‘s filings and grants, buy the databook here.

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.